Evidence map›Paper›PMID 36279287›Full record

ArticlePLoS computational biology2022

Use of compressed sensing to expedite high-throughput diagnostic testing for COVID-19 and beyond.

Kody A Waldstein, Jirong Yi, Myung Cho, Raghu Mudumbai, Xiaodong Wu, Steven M Varga, Weiyu Xu

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kody A WaldsteinInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0003-0819-1158
Jirong YiDepartment of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0002-3106-4715
Myung ChoDepartment of Electrical and Computer Engineering, Penn State Behrend, Erie, Pennsylvania, United States of America.ORCID 0000-0002-2383-3481
Raghu MudumbaiDepartment of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0001-8946-1556
Xiaodong WuDepartment of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0003-3617-5091
Steven M VargaInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0001-7332-4290
Weiyu XuDepartment of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, United States of America.
University of Iowa · USPennsylvania State University · US

Funding

PREDOCTORAL TRAINING PROGRAM IN IMMUNOLOGYT32AI007485 · NIAID · UNIVERSITY OF IOWA · PI Kevin L Legge · 1995 to 2026
$5.4M
NIAID NIH HHS T32 AI007485
6 · The paper itself

Abstract

The rapid spread of SARS-CoV-2 has placed a significant burden on public health systems to provide swift and accurate diagnostic testing highlighting the critical need for innovative testing approaches for future pandemics. In this study, we present a novel sample pooling procedure based on compressed sensing theory to accurately identify virally infected patients at high prevalence rates utilizing an innovative viral RNA extraction process to minimize sample dilution. At prevalence rates ranging from 0-14.3%, the number of tests required to identify the infection status of all patients was reduced by 69.26% as compared to conventional testing in primary human SARS-CoV-2 nasopharyngeal swabs and a coronavirus model system. Our method provided quantification of individual sample viral load within a pool as well as a binary positive-negative result. Additionally, our modified pooling and RNA extraction process minimized sample dilution which remained constant as pool sizes increased. Compressed sensing can be adapted to a wide variety of diagnostic testing applications to increase throughput for routine laboratory testing as well as a means to increase testing capacity to combat future pandemics.

Indexed as

COVID-19Clinical Laboratory TechniquesCOVID-19 TestingHumansPandemicsSARS-CoV-2Sensitivity and Specificity

Identifiers

PMID36279287
PMCPMC9632879
OpenAlexW4307171042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.